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Abstract
This study reports on an original concept of additive manufacturing for the fabrication of
tissue engineered constructs (TEC), offering the possibility of concomitantly manufacturing a
customized scaffold and a bioreactor chamber to any size and shape. As a proof of concept
towards the development of anatomically relevant TECs, this concept was utilized for the
design and fabrication of a highly porous sheep tibia scaffold around which a bioreactor
chamber of similar shape was simultaneously built. The morphology of the bioreactor/scaffold
device was investigated by micro-computed tomography and scanning electron microscopy
confirming the porous architecture of the sheep tibiae as opposed to the non-porous nature of
the bioreactor chamber. Additionally, this study demonstrates that both the shape, as well as
the inner architecture of the device can significantly impact the perfusion of fluid within the
scaffold architecture. Indeed, fluid flow modelling revealed that this was of significant
importance for controlling the nutrition flow pattern within the scaffold and the bioreactor
chamber, avoiding the formation of stagnant flow regions detrimental for in vitro tissue
development. The bioreactor/scaffold device was dynamically seeded with human primary
osteoblasts and cultured under bi-directional perfusion for two and six weeks. Primary human
osteoblasts were observed homogenously distributed throughout the scaffold, and were viable
for the six week culture period. This work demonstrates a novel application for additive
manufacturing in the development of scaffolds and bioreactors. Given the intrinsic flexibility
of the additive manufacturing technology platform developed, more complex culture systems
can be fabricated which would contribute to the advances in customized and patient-specific
tissue engineering strategies for a wide range of applications.
Keywords: additive manufacturing, bioreactor, tissue engineering, biofabrication,
custom-made scaffolds
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1. Introduction
Personalized medical therapy is an emerging practice
offering tailored solutions to each individual. This approach
is envisioned to revolutionize healthcare, through cost-
effectiveness, efficiency and improved patient outcomes.
Currently, the pharmaceutical industry is investing heavily
in this approach through the development of personalized
medicine supported by the advances in molecular and genomic
technologies [1]. To some extent, the field of tissue engineering
and regenerative medicine is following a similar path with
increasing attention given to the development of customized
tissue engineered products that would meet the patient-specific
requirements for repair and/or regeneration of tissues [2].
Additive manufacturing (AM) is one of the many
engineering technologies that have been utilized in tissue
engineering and it is central for the fabrication of customized
implants. AM builds objects layer-by-layer by gradual
deposition of materials in an organized fashion, permitting
the fabrication of three-dimensional (3D) objects with
highly complex architecture [3]. However, the development
of customized constructs of large dimensions and their
subsequent cell culture have remained challenging because of
the requirements for appropriate oxygen and nutrient diffusion
throughout the entire construct. By utilizing bioreactors,
rather than traditional static cultures, enhanced fluid diffusion
within the scaffold can be achieved, permitting in vitro
culture under highly controlled conditions [4]. Bioreactors
are usually designed to meet specific requirements for a
standardized scaffold size and shape, type of perfusion,
desired fluid flow pattern, type of applied stimulatory factors
(biochemical or biomechanical) and integrated sensorial
probes [5–11]. These points exemplify the degree of
complexity achieved in traditional bioreactors as well
as the lack of versatility when anatomical scaffolds are
considered for tissue engineering applications. Indeed, this
represents a major limitation to the generalized use of
bioreactors in personalized tissue engineering strategies as any
modifications of a standardized bioreactor chamber engender
considerable additional engineering steps and therefore result
in significantly increased labour and cost.
Control over the fluid flow pattern within the construct
is a crucial parameter for the proliferation and survival of
cultured cells in 3D. Shear stress resulting from fluid perfusion
is known to influence cell behaviour. More importantly,
perfusion is able to increase cell survival and hence culture
efficiency by avoiding the formation of regions where the
culture medium is stagnant as well as regions of high fluid
intensities capable of detaching the cells from their substrates
[12–18]. This suggests that the architecture of the bioreactor
should be similar to that of the scaffold in order to achieve
homogeneous fluid perfusion and alleviate the aforementioned
issues. A significant advance towards the development of
anatomically shaped bioreactor chambers was performed by
Grayson et al [11] who fabricated a scaffold resembling a
bovine temporomandibular joint (TMJ) condylar bone and
cultured the resulting construct in a bioreactor of similar
dimensions. The anatomically shaped bioreactor’s chamber
was produced by casting polydimethylsiloxane around a TMJ-
like mould, inserted into a cylindrical tube which was utilized
to hold the scaffold for achieving appropriate fluid transfer to
the construct’s most central portions. This technique required
multiple steps and lacked versatility for facilitating the addition
of new bioreactor features such as additional inlets and
variation in the scaffold dimensions. Although promising, this
approach still requires revision of the bioreactor design when
tailoring to suit anatomically different samples, indicating that
even though scaffolds can easily be fabricated into an array of
unique but specific anatomical dimensions, it is not necessarily
the case for bioreactor chambers.
Based on this background, we hypothesized that additive
manufacturing could be utilized to simultaneously fabricate
both the scaffold and the bioreactor chamber and provide
sufficient flexibility for rapidly manufacturing devices with
various anatomical shapes. This concept inherits a high degree
of process automation, hence enabling the fabrication of
high-quality personalized tissue engineered constructs in a
reproducible manner and at an efficient cost and speed. This
study reports on a proof of concept that additive manufacturing
involving a commercially inexpensive dual polymer extrusion
system is capable of fabricating anatomically complex
devices, comprising a custom-made ovine tibia scaffold and a
bioreactor chamber in one single step.
2. Materials and methods
2.1. Design and fabrication concept
The general design methodology employed in this study begins
with the generation of a 3D numerical model for any tissue or
organ by micro-computed tomography (micro-CT) imaging
which is then converted into a 3D replica with pre-determined
porosity. An outer shell, referred to hereafter as the bioreactor
chamber, with inlets/outlets is then designed around the
replica in order to manufacture, in one step, an anatomically
shaped device comprising an anatomically optimized scaffold
inserted into a customized bioreactor chamber. This allows
for the perfusion of the resulting scaffold during in vitro
culture, with better control of the flow and shear stress in
the system. As a proof of concept, we scanned a 3 cm ovine
tibia section by micro-CT to create a numerical 3D model
which was subsequently imported into 3Ds Max (Autodesk,
USA) software. The 3D model was vertically re-oriented
and both extremities of the tibial model were trimmed to
obtain a 3D model with a total length of 2.5 cm with
horizontally flat top and bottom surfaces (figure 1(b5)) and to
facilitate the subsequent fluid flow modelling and fabrication
steps. However, the other anatomical features of the tibia
were accurately reproduced in the resulting scaffold. The 3D
design tool, extrusion, was then used to generate a shell wall
around the lateral and top outer surfaces of the 3D model
(figure 1(b6)). The generated wall was 1 mm thick and spaced
1 mm from the 3D scaffold model’s outer surfaces. The top
part of the shell was converted into a tubular conical shape
with a slope angle of 55◦ in order to be self-supporting.
This part of the shell was designed to enable adequate fluid
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Figure 1. (a) Fluid flow modelling of various tibia-shaped (a1)–(a6) and random (a7)–(a11) device inner architectures. (a1) A rectangular
device with narrow top outlet. (a2) A rectangular device with wide top outlet. (a3) A rectangular device with a support structure (located at
the bottom) and a filler column centrally positioned with regard to the scaffold. (a4) A 2 mm-chamfered chamber with support structure,
filler column and wide outlet. (a5) A 2 mm chamfered chamber with support structure and conical outlet but without a filler column. (a6) A
2 mm chamfered chamber with support structure, filler column and conical outlet, (a7) a device with smooth lateral concavity, (a8) a device
with smooth lateral concavity complemented with fluid-homogenizing ABS supports, (a9) a device with a smooth convex shape possessing
inner lower and lateral supports, (a10) and (a11) devices adjusted to be asymmetrical employing fluid-homogenizing ABS supports.
(b) Elements of the device to be prototyped. (b1) The base of the device consisting in a lower plate designed with a mini-channel for
supplying the culture medium (red) which is covered by another plate containing two holes. (b2), (b3) The medium inlet/outlet and porous
structure positioned over the holes. (b4) The filler column centrally positioned with regard to the scaffold. (b5) The tailor-made porous
scaffold (green) positioned around the filler column. (b6) The bioreactor chamber surrounding the scaffold. (c) Fabrication and
post-processing of the device. (c1), (c2) The device after rapid-prototyping. (c3), (c4) The device after treatment with ABS/acetone solution.
(d) A micro-CT reconstruction of device. (d1), (d2) A reconstruction depicting the smooth outer ABS-made surface of the device which was
treated with ABS/acetone solution. (d3) A cross-section depicting the structure of the device containing a NaOH-treated PLA scaffold and a
central ABS filler column. (d4) The morphology of the bioreactor chamber which is characteristic of layer-by-layer deposition suggesting
that the ABS-acetone post-treatment did not affect the inner wall of the bioreactor chamber (in contrast to the outer wall shown in (d2)).
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flow in the interior of the device and to provide sufficient
space to contain extra culture medium. The top end of this
conical medium reservoir had a slope angle of 90◦ creating
an inlet/outlet structure with an inner diameter of 2 mm
onto which tubing could be connected. The bottom corners
of the chamber were additionally chamfered by 2 mm with a
slope angle of 45◦ to improve the hydrodynamic design. On
the bottom of the device, a plate containing a 1 mm wide
mini channel was designed (figures 1(b1) and (b2)), allowing
connectivity of the centre of the plate to a lateral 2 mm diameter
inlet/outlet (figure 1(b3)). Furthermore, by using the same
extrusion design tool, a plain column was also generated to
fill the empty space located in the centre of the tibia-shaped
model (figure 1(b4)).
2.2. Fluid flow modelling
A computational fluid dynamics approach was used to simulate
the flow pattern of the media in various device architectures.
The studied architectures diverged in three main aspects:
utilization of rectangular/chamfered chamber bottom corners,
the presence/absence of a central filler column for filling
the void space inside the tibia model and utilization of
wide/narrow top inlets/outlets (figures 1(a1)–(a6)). Given the
high complexity of the device, a simplified model consisting
of two-dimensional sections was created in Design Modeler
13.0 software (Ansys, USA). A profile corresponding to the
section of a tubular scaffold with a length of 2.5 cm, an outer
diameter of 13 mm and inner diameter of 6 mm was considered.
The thickness of the simplified section was 0.1 mm while a
converged free mesh was generated using automatic element
selection. Mesh independence and sufficient shape accuracy
could be reached at a maximum face size of 10 mm by applying
a free mesh. A maximum face size of 0.2 mm was utilized
in order to obtain a highly detailed and accurate solution.
The fluid flow velocity profiles were calculated using Fluent
13.0 software, within the Ansys Workbench 13.0 platform
(Ansys, USA). The pressure at the device’s outlet was assumed
to be zero and the scaffold and bioreactor chamber were
considered to be rigid and impermeable. We assumed that
the viscosity and density of the culture medium at 37 ◦C were
η = 1.45 × 10−3 Pa s and ρ = 1000 kg m−3 respectively.
To further demonstrate the versatility of our design
strategy, several scaffolds with distinct shapes and dimensions
were numerically tested with particular attention on the
homogeneity of the fluid flow profile (figures 1(a7)–(a11)).
2.3. Conversion, slicing and prototyping of 3D models
Fluid flow modelling permitted the selection of an optimized
device design which was subsequently utilized in the rest
of the study. The device’s 3D model was then sliced and
converted into a G-Code file. The volume corresponding to
the 3D tibia to be converted into a porous scaffold was
processed using the open source software Reprap (Online
Reprap Community). The 3D tibia model was sliced into
0.27 mm layers composed of deposition path lines with a
spacing of 1.5 mm. The volume corresponding to the outer
shell device was sliced and converted to G-Code files using
the open source software ReplicatorG (Online ReplicatorG
Community). The conversion was performed using two shells,
a slice thickness of 0.27 mm, an object infill of 100%, a
feed rate of 20 mm s−1 and a travel feed rate of 55 mm
s−1 as parameters. The G-Code generated through RepRap
and ReplicatorG were then merged in order to generate a single
G-Code file.
The prototyping of the devices was performed using
an open source dual extrusion rapid prototyping machine
(Replicator, Makerbot Industries, USA). The materials used
were poly(lactic) acid (PLA) Ingeo 4043D (NatureWorks
LLC, USA) for the porous scaffolds and acrylonitrile butadiene
styrene (ABS) (Makerbot industries, USA) for the bioreactor
chamber. PLA is a commonly utilized and well-accepted
material for various biomedical applications [19]. PLLA has
very good mechanical properties with a high yield stress and
is therefore a good candidate for high-load bearing bone tissue
engineering applications. ABS is widely utilized in industrial
applications, possesses the advantage of being inert and thus is
suitable for the fabrication of non-implantable devices (in this
case the bioreactor chambers). The temperature used for fusing
both materials in their corresponding nozzles was 220 ◦C. Both
materials were deposited through coordinated and alternating
operation of the nozzles.
2.4. Bioreactor surface treatment
In order to ensure that fluid leakage could not occur during
subsequent cell culture, a post-treatment coating of ABS
was applied to the outer bioreactor wall surfaces to seal any
porosity. In brief, after capping all inlets/outlets, the devices
were immersed for 2 s in an ABS/acetone 60 mg mL−1 solution
and then air-dried at room temperature for 30 min. This
procedure was performed twice. Finally, the devices were
washed several times in distilled water to remove residual
solvent.
2.5. Scaffold surface treatment
Given the hydrophobic nature of PLA, which could hinder
appropriate and homogeneous fluid perfusion through the
device, alkaline etching was performed using a 2 M sodium
hydroxide (NaOH) solution. The devices were rinsed in 100%
ethanol solution under vacuum for 1 h to pre-wet the scaffold
fibre surfaces. After the removal of the ethanol, sodium
hydroxide solution was perfused through the device until the
bioreactor was completely filled. The devices were incubated
for 30 min at room temperature under vacuum prior to a
secondary incubation at 37 ◦C for 60 min. Finally, the devices
were washed several times with distilled water and then air-
dried. In order to assess the efficacy of the NaOH treatment,
the same protocol was performed on 8 mm cubic scaffolds
with similar architecture but not inserted in the device. Images
of fluid infiltration within the scaffolds prior to and after
NaOH treatment were taken using a digital camera. The
alkaline etching (NaOH treatment) was utilized to increase the
hydrophilicity of the scaffold surface. Base or acid treatments
have been shown to increase the surface density of carboxylic
acid groups of aliphatic polyester. This is generally associated
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with an increase in the surface roughness and enhanced cell
attachment [20, 21]. However, the device developed in this
study enables any type of surface modification as long as it is
performed in an aqueous environment. We have demonstrated
in a previous work that a calcium phosphate coating can
be performed on scaffolds resulting in enhanced alkaline
phosphatase activity, mineralization and bone formation in
osteoblast-seeded scaffolds [22].
2.6. Micro-computerized tomography analysis (micro-CT)
The devices were analyzed by micro-CT (μCT40, SCANCO
Medical AG, Bru¨ttisellen, Switzerland) at a resolution of
12 μm, a voltage of 55 kVp and a current of 175 μA. 3D
images were reconstructed from the scans by the micro-CT
system software.
2.7. In vitro study
Cell culture took place over six weeks and was performed
under bi-directional perfusion. A 1 mL sterile syringe was
connected to the device’s medium inlet using sterile silicone
tubing (figures 3(a1) and (a2)). This apparatus was mounted
on a multi-syringe adapter placed on an Aladdin syringe
pump (World Precision Instruments, USA). A total of six
devices (each with a dedicated syringe) were simultaneously
cultured in this system. The devices were first sterilized by
perfusion with 50% ethanol solution for 20 min and dried
in a sterile biohazard safety cabinet for 2 h. The devices were
manually filled with 4 mL of basal medium and bi-directionally
perfused overnight at a flow rate of 0.4 mL min−1 with flow
direction inversion every 100 s using the syringe system. This
hydration step aimed to promote the pre-adsorption of proteins
to the scaffold surfaces and hence facilitate subsequent cell
attachment. In order to ensure the sterility of the device during
the culture period while still allowing gas exchange with the
incubator’s environment, a 0.2 μm pore size filter (13 mm
diameter) (Pall, USA) was connected to the outlet positioned
at the top of the device.
Primary human osteoblasts were collected from a patient
undergoing hip surgery. Ethics approval for the use of
human osteoblasts in this experiment was granted from The
Prince Charles Hospital ethics committee (ethics clearance
number: EC2310) and Queensland University of Technology
ethics committee (ethics clearance number 0600000232). The
osteoblasts were expanded in basal alpha MEM modified
medium (Gibco, USA) supplemented with 10% foetal calf
serum and 1% penicillin/streptomycin and used at passage
2. When reaching confluence, the cells were trypsinized and
aliquots of 1 × 106 osteoblasts in 250 μl of media were
prepared. The medium previously contained in each device
was then mixed with a cell suspension aliquot and perfused
back into the device through the silicone tube. The devices
were bi-directionally perfused for 24 h at a flow rate of
0.4 mL min−1 in order to allow cell attachment. The perfusion
direction was automatically inverted every 100 s utilizing an
external microcontroller connected to the syringe pump.
After 24 h, the culture medium was replaced by fresh
medium and the flow rate was increased to 0.8 mL min−1
whereas the flow inversion frequency was reduced to
50 s. The medium was changed weekly and the scaffolds
were collected for analysis at two and six weeks post-
seeding. The samples were analysed after two weeks of
culture as a low amount of cells was initially seeded in
order to test the device’s ability to support cell proliferation.
The six weeks time point was chosen in order to assess
the system’s ability to maintain sterility and cell viability
over a prolonged period of time. The scaffold collection was
performed as follows: the devices were detached from the
syringe pump by removing the silicone tubings and placed in
a sterile biohazard safety cabinet. The scaffolds were retrieved
from the interior of the bioreactor chamber by manually
sectioning the bioreactor walls using sterile tweezers and
scissors. The collected scaffolds were processed for either 3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) staining, live/dead assay, confocal laser scanning or
electron microscopy.
2.8. Metabolic activity staining
Metabolically active cells were visualized by using
a 1 mg mL−1 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) solution. Following retrieval, the
scaffolds were washed in phosphate buffered saline (PBS) and
then immersed into MTT solution for 30 min. Images were
captured by a digital camera mounted on an Eclipse TS100
microscope (Nikon, Tokyo, Japan).
2.9. Live/dead assay (FDA/PI)
Cell viability was assessed using a live/dead assay. The
scaffolds were washed twice in PBS, incubated for 5 min
at 37 ◦C in PBS containing 0.67 μg mL−1 fluorescein
diacetate (FDA) and 5 μg mL−1 propidium iodide (PI)
(both Invitrogen) and washed again in PBS. The cellularized
scaffolds were analysed using a confocal laser scanning
microscope (Leica TCS SP5, Leica Microsystems, GmbH).
The excitation/emission wavelengths used for imaging the
FDA and PI stainings were respectively 488/518–568 and
561/598–795 nm. A semi-quantitative analysis of the cellular
viability was performed using ImageJ software to quantify
living cells (green) and dead cells (red). A total of seven
images from multiple regions of interest of the constructs were
captured and analysed for each time point.
2.10. Scanning electron microscopy
Osteoblast morphology and distribution in the scaffold was
assessed at two and six weeks post-seeding by scanning
electron microscopy (SEM). In brief, samples were fixed in
3% glutaraldehyde, washed in 0.1 M cacodylate buffer and
post-fixed in 1% osmium tetroxide in cacodylate buffer for
1 h, prior to dehydration through sequential graded series
of ethanol concentrations. Finally, samples were immersed
in hexamethyldisilazane for 60 min, air-dried, mounted onto
aluminium stubs and gold coated. Samples were observed on
a FEI Quanta 200 Environmental SEM operating at 10 kV.
Scaffolds without cells were gold coated prior to imaging.
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3. Results and discussion
The objective of this study was to develop and assess
an innovative biofabrication-rooted technology platform for
simultaneously generating anatomically shaped scaffolds and
bioreactor chambers. Additive manufacturing is commonly
used for fabricating scaffolds for tissue engineering, however
it is rarely utilized for manufacturing functional bioreactors.
This study is, to our knowledge, the first report on the
utilization of rapid prototyping for designing anatomically
shaped bioreactors and scaffolds in one manufacturing
step. The versatility provided by additive manufacturing
technologies enables the design and fabrication of highly
complex scaffolds which raise a realm of new possibilities,
yet also new challenges strongly related to the in vitro
culture methods. Indeed, seeding methods are yet to be
developed for homogenously distributing the cells through
large volume scaffolds such as the ones utilized in this study.
Also, an adequate supply of nutrients and oxygen throughout
the entire construct is another parameter of importance for
the generation of viable tissue substitutes. Unlike small
and regular-shaped scaffolds, the seeding and culture of
customized and/or patient-specific scaffolds of large size
and volume requires a greater degree of complexity in their
design for achieving appropriate in vitro tissue development.
In the context of personalized regenerative strategies, highly
versatile manufacturing platforms are required for fabrication.
Hence, the methodology developed in this work intends to
circumvent the above-mentioned challenges while still being
cost effective.
3.1. Fluid flow modelling
Control over the fluid pattern within perfused scaffolds is
essential to achieve effective in vitro culture conditions.
Homogenous and laminar flow patterns are among the
main features defining an optimal culture system. Therefore,
multiple culture chamber designs fitting the outer shape of
the tibia section model were tested in order to define the
most appropriate design by varying several parameters such
as the utilization of rectangular or chamfered chamber bottom
corners, the presence or absence of an inner filler column and
wide (same diameter as the scaffold) or narrow top (2 mm
diameter) inlet/outlet. Figure 1(a) depicts the velocity profile
of the media perfused in these devices as obtained by numerical
modelling. It was observed that chamfered geometries were
the most efficient in avoiding low velocity sites, in contrast to
rectangular geometries where fluid velocities in the vicinity
of the rectangular lower corners dropped to under 2.5%
of the inlet fluid velocity. Hidalgo-Bastida et al utilized
computational fluid modelling for predicting and comparing
fluid patterns into rectangular or circular bioreactor chambers.
It was shown that a circular geometry was the most suitable
for avoiding both the formation of stagnant zones in the
peripheral regions of the scaffolds and high fluid velocity near
the chamber’s inlets/outlets [23]. However, the regions located
between the scaffold and the chamber’s inlets/outlets were not
taken into account despite potential media accumulation in
these areas. Figures 1(a1)–(a3) clearly show that rectangular
bottom corners are prone to the formation of stagnant regions
and this is of particular relevance for vertically oriented
perfusion chambers and can induce cell apoptosis caused by
a lack of nutrients and oxygen. However, this is eliminated to
a large extent by the optimized geometry of the bioreactor
chamber (figures 1(a4)–(a6)) where fluid velocities were
always kept 2.5% above the initial fluid velocity. The design
was further optimized by adding an ABS porous support
structure at the base of the bioreactor (figures 1(a3)–(a6)),
which proved highly efficient at placing the scaffold away
from both stagnant and high fluid velocity regions.
The design of a column internal to the scaffold’s void
central part allowed efficient steering of the media towards the
central region of the scaffold (figures 1(a3), (a4) and (a6)).
This also contributed to an increase in the fluid velocity in
the scaffold to 15–20% of the initial value and resulted in a
more homogeneous fluid velocity being established. This is in
contrast to the design without the ABS column where the fluid
velocity was much lower (5–7.5%) and highly heterogeneous
(figures 1(a5) and (a6)). Taking into consideration that the
initial flow rate was 0.8 mL min−1, this column design resulted
in an homogeneous flow rate of 0.12–0.16 mL min−1 in the
scaffold, which is similar to what was found in previous studies
where flow rates within this range positively influenced cellular
proliferation and development while at the same time avoiding
cell detachment caused by high shear stress [12, 24].
The utilization of a wide or narrow inlet/outlet
configuration at the top of the device did not significantly
affect the flow pattern in the device, however the narrow outlet
configuration (figure 1(a6)) was selected for the subsequent
in vitro culture, as it would effectively reduce the risk of
contamination by permitting the attachment of a sterile air
filter.
We further demonstrated the versatility of the design
strategy by testing more complex and technically challenging
sizes, shapes and volumes (figures 1(a7)–(a11)). We were
able to show that the outer shape of the bioreactor chamber
accurately followed the geometrical features of the scaffold to
a certain degree of concavity without significantly affecting
fluid velocity homogeneity (figure 1(a7)). When the degree of
concavity was too high, a porous ABS support was introduced
in the lower and lateral part of the device in order to provide
structural support and ensure fluid velocity homogeneity
(figures 1(a8) and (a9)). The introduction of porous ABS
supports also proved to be effective in enabling fluid flow
homogeneity in cases of asymmetrical scaffold profile designs
(figures 1(a10) and (a11)).
3.2. Design, fabrication and post-processing of the device
Taking into consideration the results obtained from the fluid
flow modelling and considering the specific needs for the
development of a perfusion bioreactor, an optimized device
design was achieved by 3D modelling in the 3Ds Max Software
((figure 1(b)). The bottom part of the device consisted of a
base plate into which a mini channel was integrated
(figures 1(b1) and (b2)) to supply sufficient culture medium
into the device. A tubular structure was added at one end of
the channel to connect the chamber to the culture medium
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(a) (b)
(c ) (d )
(e) (f )
Figure 2. Effect of NaOH treatment. (a) and (b) Scanning electron micrographs obtained from the surface of untreated, (a) and (b) and
NaOH-treated scaffold (c) and (d). (e) Scaffold retrieved from the device. ( f ) Increased hydrophilicity resulting from the NaOH treatment,
untreated (left) and NaOH-treated test scaffolds (right) when hydrated with culture medium.
reservoir. As already described in the previous section, a
porous ABS structure was placed at the bottom of the device
to allow homogenous fluid distribution (figure 1(b3)). This
porous support was 1 mm thick and possessed a cross-section
similar to that found in the anatomically shaped scaffold.
Figure 1(b4) shows the filler column utilized to steer the
medium towards the central portions of the scaffold and
reduce the volume of medium necessary for cell seeding and
subsequent culture. A 1 mm spacing was maintained between
the column and the scaffold to permit fluid circulation in these
locations (figure 1(b5)). Finally, an outer bioreactor chamber
was designed around the scaffold and its porous support
(figure 1(b6)). This chamber was positioned 1 mm from the
scaffold and matched the anatomical shape of the scaffold.
While further reducing the volume of medium utilized during
the in vitro culture, this also allowed greater control over
the fluid flow pattern. Indeed, a bioreactor chamber that
accurately follows the shape of the scaffold ensures effective
circulation of the culture medium through the interior of
the construct, not only around its periphery. As seen in the
fluid flow simulations, the hydrodynamic design provided by
both the inner column and the bioreactor chamber resulted
in homogenous fluid patterns throughout the interior of the
scaffold. Commercially available bioreactor culture systems
7
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(a)
(b)
Figure 3. (a) The structure of the cell culture apparatus. (a1) A schematic representation of the device being bi-directionally perfused with
culture medium using a syringe mounted onto a syringe pump. (a2) The device with the upper inlet capped with a syringe filter to preserve
sterility and for gas exchange. A silicone tube is connected to the lower inlet/outlet for bi-directional circulation of the culture medium.
(b) The procedure for retrieving the construct from the culture device by manually breaking and cutting with the aid of sterile scissors and
tweezers.
such as the U-Cup (Cellec Biotek AG, Switzerland) have
shown that bi-directional perfusion enhances cell seeding
efficiency and distribution and results in more reproducible
bone formation [6, 25]. In contrast to our device, the U-Cup
is only capable of culturing small cylindrical constructs and
hence lacks the versatility required for tailor-made applications
in which the construct’s shape and architecture need to be
optimized on a case-to-case basis.
The final design (figure 1(b6)) was saved as an STL file,
converted to G-Code using RepRap and ReplicatorG softwares
and finally prototyped by the Makerbot. The fabrication time
for each device was 45 min. As some open porosity remained
within the bioreactor chamber, a post-treatment with an ABS
solution was utilized in order to seal these pores ensuring that
no leakage would occur during the subsequent cell culture.
Acetone-based solutions are commonly used as cements for
repairing, welding and smoothing, as well as for waterproofing
structures made of ABS [26, 27]. As shown in figure 1(d), the
treatment reduced the outer surface roughness of the bioreactor
chamber and all interlayer micro-gaps were eliminated. This
significantly affected the appearance of the chamber’s outer
wall as shown in figure 1(c) as the post-treated material
appeared smoother with a glossy finish.
The NaOH post-treatment on the PLA scaffold resulted in
high surface roughness and consequently higher hydrophilicity
when compared to untreated samples (figure 2), which was in
accordance with a previous study [28]. This post-treatment
exemplifies the fact that other types of surface modification
can be performed on the scaffold by simply perfusing fluids
within the device such as simulated body fluid for a biomimetic
coating [29–31].
The high versatility provided by additive manufacturing,
combined with the concept we have developed in this
study, permits and facilitates the optimization of numerous
devices with different shapes and sizes where various design
features such as additional inlets/outlets can be incorporated.
Indeed, unlike traditional bioreactors, one major advantage
of this manufacturing strategy is that both culture chamber
and scaffold designs can be freely modified and optimized
according to the intended tissue engineering application
without any additional engineering steps or increased
costs.
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Figure 4. (a) MTT staining of human osteoblast-cultured scaffolds after two and six week culture times. (b) Scanning electron micrographs
of human osteoblast-cultured scaffolds after two and six week culture times. (c) FDA/PI viability staining of human osteoblast-cultured
scaffolds after two and six week culture times showing viable cells in green and dead cells in red.
In this proof-of-principle study, a scaffold design for a
well-established large preclinical animal model was chosen,
namely for regenerating a large segmental defect of a sheep
[32]. Scaffolds with more complex shapes and heterogeneous
architectures could be fabricated using the method described
in this study (see supplementary figure 1 (available
from stacks.iop.org/BF/6/035006/mmedia)). The mechanical
properties of such scaffolds can also be highly tuneable through
optimizing the processing parameters. In a study by Ciurana
et al [33] it was shown that, by simply varying parameters
such as degree of porosity, deposition angle, slenderness
and distance between filaments, scaffolds very similar to
those employed in this work could reach Young’s modulus
values as high as 1,2 GPa which is greater than Young’s
modulus of cancelous bone (0.02–0.5 GPa) and around 50%
of the lower range of Young’s modulus of cortical bone
(3–30 GPa) [34]. In order to reach Young’s modulus values
within the range found in cortical bone, reinforcements such
as hydroxyapatite can further be added to PLA generating
composite materials with enhanced mechanical properties
[35]. The high versatility in the design and manufacturing
of both the scaffold and the culture chamber is the main
characteristic that distinguishes this technology platform from
other current scaffold-based bone tissue engineering strategies.
For instance, a comparison with the strategy developed by
Grayson et al [11] clearly shows the superior properties of our
concept with regard to design and manufacturing. Indeed, the
fabrication is performed in a single step while allowing the
maintenance of a high degree of accuracy in the architecture
and the shape of the scaffold and/or bioreactor chamber.
3.3. Perfusion cell culture
The perfusion bioreactor was composed of various devices
with their top air inlet/outlets capped with syringe filters
(figure 3(a2)) and connected to individual syringes mounted
into one single syringe pump by means of a multi-syringe
adapter (figure 3(a1)). After an overnight incubation of the
scaffold in culture medium, the cell suspension was injected
into the device and the bi-directional perfusion was applied
to achieve homogeneous seeding. After two and six weeks
of culture, the scaffolds were collected by manually opening
the devices utilizing sterile scissors and tweezers as depicted
in figure 3(b). The MTT staining revealed the distribution of
viable cells at two and six weeks (figure 4(a)). Indeed cells
were well-distributed throughout the length of the scaffold,
and also on the outer and inner portions of the architecture
confirming that appropriate in vitro culture conditions were
achieved. The MTT staining observations were corroborated
by SEM analysis (figure 4(b)) which showed homogeneous
cell distribution and intimate attachment onto the scaffold. It
was also observed that the cells were covering the polymer
struts of the scaffold, although this was more pronounced at
six weeks post-seeding. In some cases cells were capable of
spanning the nearby struts as shown in figure 4(b).
FDA/PI staining and confocal laser scanning microscopy
confirmed the homogeneity of the cell distribution while
assessing their viability (figure 4(c)) despite the technical
challenges encountered when imaging samples of larger
dimensions via confocal laser microscopy. Therefore, the
scaffolds were divided into three zones—top, middle and
bottom—similarly to what was performed in the rest of
9
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Table 1. Statistical analysis of percentage of live cellular content in
cultured samples.
2 weeks 6 weeks
Percentage of live cells (%) 70.15 ± 10.14 74.29 ± 18.45
this study. This revealed that, despite the presence of some
necrotic cells (stained in red), the vast majority of the cells
were alive (green). No significant difference in cell viability
was observed when semi-quantitatively comparing the various
sites of the construct. Although a slight increase in necrotic
cells in the bottom region was observed, it did not reach
statistical significance. The percentage of living cells at two
and six weeks was 70% ± 10 and 74% ± 18 respectively
(table 1). These results demonstrate that nutrients were able to
homogeneously diffuse throughout the entire perfusion device,
resulting in an even distribution of viable cells in the scaffold
and validating the fluid flow model predicting a homogenous
flow pattern inside the device.
4. Conclusions
This study presents a unique concept based on additive man-
ufacturing for the integrated and simultaneous manufacturing
of anatomically shaped scaffolds and customized bioreactor
chambers. We foresee that this innovative concept will repre-
sent a significant advance in further implementing the currently
available biofabrication toolbox towards the development of
automated customization of tissue engineered products.
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